Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Advanced Gastric Cancer
Interventions
DRUG

MODIFIED FOLFOX6

Modified FOLFOX6 regimen consists of oxaliplatin 100 mg/m2 and FA 100 mg/m2 given as a 2 hour intravenous infusion, followed by 5-FU 2.4 g/m2 given as a continuous infusion over 46 hour, repeated every 2 weeks. Patients receive 4 cycles of neoadjuvant modified FOLFOX6 followed by curative radical surgery with D2 dissection and 4 cycles of adjuvant modified FOLFOX6.

Trial Locations (2)

Unknown

Seoul National University Bundang Hospital, Seongnam

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02142322 - Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter